Pneumococcal Vaccine Offers Protection to HIV-Infected African Adults in Clinical Trial, University of Malawi College of Medicine Study

ScienceDaily (Apr. 4, 2010) — A clinical trial of a vaccine against a major cause of pneumonia and meningitis has shown that it can prevent three out of four cases of re-infection in HIV-infected adults in Africa.

MORE ON THIS TOPIC